Boehringer Ingelheim’s Respimat Inhaler, designed for those with arthritis, has received the Arthritis Foundation Ease of Use Commendation.
The commendation is awarded to “products proven to make life easier for people with arthritis and other physical limitations,” the foundation said. The goal is for product design or packaging to meet the needs of those with arthritis.
The inhaler allows medication to move through a slow mist, letting patients breathe in the medication more slowly. It also eliminates patients having to sharply inhale.
The Respimat Inhaler was tested by experts at the Intuitive Design Applied Research Institute lab in Atlanta and evaluated by people with arthritis.
“We are proud of our Respimat inhaler as being the first and only inhaler recognized by the Arthritis Foundation as easy to use for everyone,” said Jean-Michel Boers, president, Human Pharma, Boehringer Ingelheim Pharmaceuticals.